Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.27618 | 69 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.27522 | 69 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.28147 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.77189 | 73 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.22309 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.28692 | 69 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.69556 | 60 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.45828 | 71 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.20684 | 68 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.27075 | 69 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.26457 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.54359 | 71 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.32377 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.53201 | 72 |